Hedley Atkins Breast Unit, Guy's Hospital, London, UK.
Eur J Surg Oncol. 2011 Dec;37(12):1051-8. doi: 10.1016/j.ejso.2011.07.005. Epub 2011 Aug 16.
In breast cancer patients (≥70 years), tumour resection plus tamoxifen (T + T) has a higher loco-regional relapse (LR) rate than mastectomy. This study examines factors influencing local recurrence in these cases.
Clinical records of 71 patients aged ≥70 years, randomised to the T + T arm of 2 randomised trials were reviewed. Cox Proportional Hazards model was used to determine the most significant variables.
After 15-years follow-up, LR relapse occurred in 29/71, of whom 5 had synchronous metastatic disease. Most tumours recurred in the index quadrant. Subsequently 21/24 patients with loco-regional recurrence only had salvage mastectomy. Three variables significantly predicted LR: lympho-vascular invasion (LVI) (HR [95% CI]: 11.18 [4.47, 27.95], p < 0.01), ER negative status (HR [95% CI]: 0.27 [0.10, 0.72] p = 0.01), and tumour necrosis (HR [95% CI]: 2.65 [1.10, 6.37], p = 0.03). Final margin status was not associated with LR.
Tumour resection + Tamoxifen in older patients results in long-term local control in the majority with most loco-regional failures being salvageable. Risk factors for LR are lympho-vascular invasion, ER status and tumour necrosis. Negative tumour excision margins did not significantly change local outcome in the absence of radiotherapy. In these older patients LVI significantly reduced survival time.
在≥70 岁的乳腺癌患者中,肿瘤切除术加他莫昔芬(T+T)的局部区域复发(LR)率高于乳房切除术。本研究探讨了这些病例中影响局部复发的因素。
回顾了 71 名年龄≥70 岁的患者的临床记录,这些患者随机分配到 2 项随机试验的 T+T 组。使用 Cox 比例风险模型确定最显著的变量。
在 15 年的随访后,71 例患者中有 29 例出现 LR 复发,其中 5 例伴有同步转移性疾病。大多数肿瘤在索引象限复发。随后,24 例局部区域复发患者中仅 21 例进行了挽救性乳房切除术。有 3 个变量显著预测 LR:淋巴血管侵犯(LVI)(HR [95%CI]:11.18 [4.47, 27.95],p<0.01)、ER 阴性状态(HR [95%CI]:0.27 [0.10, 0.72],p=0.01)和肿瘤坏死(HR [95%CI]:2.65 [1.10, 6.37],p=0.03)。最终切缘状态与 LR 无关。
在大多数患者中,老年患者的肿瘤切除术+他莫昔芬可实现长期局部控制,大多数局部区域复发可挽救。LR 的危险因素是淋巴血管侵犯、ER 状态和肿瘤坏死。在没有放疗的情况下,肿瘤切除边缘阴性并不能显著改变局部结果。在这些老年患者中,LVI 显著降低了生存时间。